News

The acquisition, which is subject to customary closing conditions, is expected to be completed in the first quarter of fiscal 2015. The deal is expected to double the

OncoExplorer is the latest addition to the RainTree Analytics suite of products. Information Builders’ iWay integration and integrity products have been used by RainTree Oncology Services to implement

PSX1001 and PSX1050 are being developed as generic versions to GlaxoSmithKline’s pressurised metered dose inhalers (pMDI) Flixotide and Flovent, respectively. Flixotide and Flovent contain the active ingredient fluticasone

Rasuvo, which is currently under FDA review, is being developed for multiple indications, including rheumatoid arthritis (RA), poly-articular-course juvenile RA and psoriasis. The drug is designed to improve

AKB-6548, a once-daily, oral investigational therapy, is designed to achieve a coordinated and natural increase in red blood cell production and iron utilization that is similar to the

RLB Holdings managing partner and co-founder Lydia Bartoszek said: "The vision of Kineta-RLB is to progress the clinical development in high need areas with the hope of improving

Following this the Consumer Healthcare division of Sanofi Korea is making a major launch of Probi´s gut health product, Probi Digestisstarting in April 2014. Probi has already delivered

New participant Novo Ventures and existing investor Third Rock Ventures co-led this round of financing, which also included founding investor SV Life Sciences. Novo Ventures senior partner Dr

Under the terms of the agreement, Actavis will grant Mylan a license to market its generic version of Generess FE under its pending Abbreviated New Drug Application (ANDA)